Published in J Immunol on September 01, 1972
Autogenous immunity to endogenous RNA tumor virus. Radioimmune precipitation assay of mouse serum antibody levels. J Exp Med (1973) 2.31
Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody. Appl Microbiol (1973) 2.23
Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85
Solid phase radioimmunoassay for identification of Herpesvirus hominis types 1 and 2 from clinical materials. Appl Microbiol (1974) 1.63
Antigenic components of group A arbovirus virions. J Virol (1973) 1.30
Avian oncornavirus group-specific antigen: detection and quantification by radioimmunoassay. J Virol (1973) 1.09
Group B arbovirus structural and nonstructural antigens. 3. Serological specificity of solubilized intracellular viral proteins. Infect Immun (1973) 1.08
Solid-phase radioimmunoassay for antibodies to flavivirus structural and nonstructural proteins. Infect Immun (1976) 1.01
Structural components of Oriboca virus. J Virol (1974) 0.93
Detection of alphaviruses in a genus-specific antigen capture enzyme immunoassay using monoclonal antibodies. J Clin Microbiol (1991) 0.89
Identification of immunologically cross-reactive proteins of Sindbis virus: evidence for unique conformation of E1 glycoprotein from infected cells. J Virol (1984) 0.88
Infectious virus-antibody complexes of sindbis virus. Infect Immun (1977) 0.88
Comparison of specific and cross-reactive antigens of alphaviruses on virions and infected cells. Infect Immun (1982) 0.85
Solid-phase radioimmunoassay as a method for evaluating antigenic differences in type A influenza viruses. Infect Immun (1977) 0.80
Comparative study of 125 I- and (3H)acetate-labeled antibodies in detecting iridescent viruses. Appl Microbiol (1974) 0.75
Solid-phase radioimmunossay for rapid detection and identification of western equine encephalomyelitis virus. J Clin Microbiol (1976) 0.75
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol (1992) 12.96
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A (1992) 8.59
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Quantitative microtiter cytotoxicity assay for Shigella toxin. J Clin Microbiol (1980) 7.68
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol (1989) 7.06
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (1994) 5.34
Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses. Virology (1988) 4.78
Roles for Nkx3.1 in prostate development and cancer. Genes Dev (1999) 4.30
Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens. J Immunol (1976) 4.02
Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J (1999) 3.79
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med (2001) 3.51
Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science (1985) 3.17
Flaviviridae. Intervirology (1985) 3.06
Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res (2001) 2.97
Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun (1976) 2.67
Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell (1998) 2.64
The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64
Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature (1982) 2.64
Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57
Bunyaviridae. Intervirology (1980) 2.53
Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol Cell Biol (1998) 2.48
Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45
Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am J Trop Med Hyg (1982) 2.41
Structural relationships between the RNA of mammary tumor virus and those of other RNA tumor viruses. Virology (1968) 2.39
Coding strategy of the S genome segment of Hantaan virus. Virology (1986) 2.36
Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing. Virology (1976) 2.32
Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc Natl Acad Sci U S A (1987) 2.26
Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae. Virology (1994) 2.20
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci U S A (2000) 2.19
v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci U S A (1990) 2.16
Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order. Virology (1987) 2.10
Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev (1994) 2.05
Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol (2001) 2.02
Expression of AIDS virus envelope gene in recombinant vaccinia viruses. Nature (1986) 1.98
Infection of cultured rat hepatoma cells by mouse mammary tumor virus. Cell (1977) 1.98
Togaviridae. Intervirology (1985) 1.96
Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95
Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94
CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol (1998) 1.93
E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol Cell Biol (2001) 1.91
Protein kinase CK2 in mammary gland tumorigenesis. Oncogene (2001) 1.90
Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis (1977) 1.88
Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85
Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology (1983) 1.83
Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome. J Infect Dis (1983) 1.82
Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80
Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79
Sindbis virus mutations which coordinately affect glycoprotein processing, penetration, and virulence in mice. J Virol (1989) 1.75
Immunoprecipitation analysis of soluble complement-fixing antigens of dengue viruses. J Immunol (1970) 1.69
Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses. Virology (1972) 1.69
Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69
An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg (1968) 1.68
Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol (2001) 1.68
Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun (1980) 1.67
Immunological and biophysical separation of dengue-2 antigens. J Virol (1971) 1.66
Anti-dengue immunoglobulins and serum beta 1 c-a globulin levels in dengue shock syndrome. J Immunol (1969) 1.64
The proteins of Japanese encephalitis virus. Virology (1971) 1.63
An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann Intern Med (1967) 1.61
Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol (1989) 1.59
Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58
Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol (1989) 1.58
Bunyaviruses and Bunyaviridae. Intervirology (1976) 1.58
Structure of the mouse mammary tumor virus: polypeptides and glycoproteins. J Virol (1974) 1.56
Isolation of St. Louis encephalitis virus from overwintering Culex pipiens mosquitoes. Science (1978) 1.53
Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol (1990) 1.51
Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun (1977) 1.51
Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47
MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol (1999) 1.44
Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun (1979) 1.44
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene (2001) 1.42
Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus. Virology (1985) 1.41
Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg (1978) 1.39
Partial nucleotide sequence of the Japanese encephalitis virus genome. Virology (1987) 1.39
Activated neu induces rapid tumor progression. J Biol Chem (1996) 1.39
Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J Infect Dis (1977) 1.39
Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak. J Infect Dis (1977) 1.38
Structure of the Ockelbo virus genome and its relationship to other Sindbis viruses. Virology (1991) 1.38
Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus. Virology (1989) 1.38
Partial purification and characterization of a dengue virus soluble complement-fixing antigen. J Immunol (1970) 1.37
Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals. Infect Immun (1991) 1.37
Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Mol Cell Biol (1996) 1.36
Selective amplification of mouse mammary tumor virus in mammary tumors of GR mice. J Virol (1980) 1.36
Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol (1971) 1.36
Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res (2000) 1.35
Structure of the mouse mammary tumor virus: characterization of bald particles. J Virol (1974) 1.35
Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg (1970) 1.33
Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology (1989) 1.33
Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis (1971) 1.33
Antigenic components of group A arbovirus virions. J Virol (1973) 1.30